NEOMYCIN; POLYMYXIN B SULFATES; DEXAMETHASONE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

100 API Suppliers, 27 USDMF, 14 CEP/COS, 6 JDMF, 8 EU WC, 8 KDMF, 28 NDC API, 1 VMF, 51 Listed Suppliers

DEVELOPMENTS

412 Drugs in Development

412 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

526 FDF Dossiers, 131 FDA Orange Book, 271 Europe, 26 Canada, 10 Australia, 18 South Africa, 70 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.1%, SUSPENSION/DROPS;OTIC - 0.3%;0.1%, OINTMENT;OPHTHALMIC - 0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM, SUSPENSION/DROPS;OPHTHALMIC - 0.1%;0.3%, OINTMENT;OPHTHALMIC - 0.1%;0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.05%;0.3%, TABLET;ORAL - 0.5MG, TABLET;ORAL - 0.75MG, TABLET;ORAL - 1.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, TABLET;ORAL - 4MG, TABLET;ORAL - 6MG, SOLUTION;ORAL - 0.5MG/5ML, CONCENTRATE;ORAL - 1MG/ML, ELIXIR;ORAL - 0.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 7 SPI Pharma, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 6 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 9 Kirsch Pharma, 8 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 15 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 3 CD Formulation, 10 Corel Pharma Chem, 6 DFE Pharma, 3 Finar, 8 Gangwal Chemicals, 2 Gloria Interchem, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 15 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

53 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 28 Direct Compression, 28 Parenteral, 27 Thickeners and Stabilizers, 25 Solubilizers, 21 Granulation, 18 Film Formers & Plasticizers, 18 Controlled & Modified Release, 17 Taste Masking, 17 Topical, 16 Disintegrants & Superdisintegrants, 13 Co-Processed Excipients, 12 Lubricants & Glidants, 11 API Stability Enhancers, 9 Emulsifying Agents, 9 Chewable & Orodispersible Aids, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 2 Stock Recap #PipelineProspector, 291 News #PharmaBuzz

GLOBAL SALES INFORMATION

39 US Medicaid Prescriptions, 47 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

72 APIs, 61 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 2 US Exclusivities, 5 Health Canada Patents

REF. STANDARDS & IMPURITIES

8 EDQM, 6 USP, 2 JP, 16 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls

Filters

Xls

USFDA APPLICATION NUMBER - 88254 / DOSAGE - ELIXIR;ORAL - 0.5MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Dexamethasone(UNII: 7S5I7G3JQL) (Dexamethasone - UNII:7S5I7G3JQL)	Dexamethasone	0.5mg in 5

Inactive Ingredients

Ingredient Name	Cardinal Health
Alcohol(3K9958V90M)
Anhydrous Citric Acid(XF417D3PSL)
Benzoic Acid(8SKN0B0MIM)
FD&C Red No. 40(WZB9127XOA)
Propylene Glycol(6DC9Q167V3)
Raspberry(4N14V5R27W)
Sodium Citrate(1Q73Q2JULR)
Sucrose(C151H8M554)
Water(059QF0KO0R)

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Setid Dfb8cd15 E468 4082 8e68 4f1d4ad7f283 Applno 88254 Form Elixir Oral Dosage 0 5mg 5ml - Drug Product Composition: NEOMYCIN; POLYMYXIN B SULFATES; DEXAMETHASONE